Intellia Therapeutics has reported positive Phase 3 results for lonvoguran [...]

Nature publishes Phase 1b data showing NETRIS Pharma’s NP137 improves [...]

Myomaker Bio, a UK biotechnology company spun out from Loughborough [...]

Viz.ai has entered a collaboration with Johnson & Johnson to [...]

Veristat has agreed to acquire Certara’s regulatory and medical writing [...]

Merck has launched a portfolio of bio-based solvents for high-performance [...]

Eascra Biotech is advancing DNA-inspired nanomaterials developed with ISS National [...]

Neomorph has closed a $100 million Series B financing to [...]

Oncodesign Services has expanded its collaboration with French research institute [...]

Regeneron Pharmaceuticals has entered the radiopharmaceuticals field through a multi-programme [...]